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The solution structure of the amino-terminal HHCC domain of
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Background: Integrase mediates a crucial step in the life cycle of the human
immunodeficiency virus (HIV). The enzyme cleaves the viral DNA ends in a
sequence-dependent manner and couples the newly generated hydroxyl groups
to phosphates in the target DNA. Three domains have been identified in HIV
integrase: an amino-terminal domain, a central catalytic core and a carboxy-
terminal DNA-binding domain. The amino-terminal region is the only domain with
unknown structure thus far. This domain, which is known to bind zinc, contains a
HHCC motif that is conserved in retroviral integrases. Although the exact
function of this domain is unknown, it is required for cleavage and integration.
Results: The three-dimensional structure of the amino-terminal domain of HIV-2
integrase has been determined using two-dimensional and three-dimensional
nuclear magnetic resonance data. We obtained 20 final structures, calculated
using 693 nuclear Overhauser effects, which display a backbone root-mean
square deviation versus the average of 0.25 Å for the well defined region. The
structure consists of three α helices and a helical turn. The zinc is coordinated
with His12 via the Nε2 atom, with His16 via the Nδ1 atom and with the sulfur
atoms of Cys40 and Cys43. The α helices form a three-helix bundle that is
stabilized by this zinc-binding unit. The helical arrangement is similar to that
found in the DNA-binding domains of the trp repressor, the prd paired domain
and Tc3A transposase.
Conclusion: The amino-terminal domain of HIV-2 integrase has a remarkable
hybrid structure combining features of a three-helix bundle fold with a zinc-
binding HHCC motif. This structure shows no similarity with any of the known
zinc-finger structures. The strictly conserved residues of the HHCC motif of
retroviral integrases are involved in metal coordination, whereas many other well
conserved hydrophobic residues are part of the protein core.
Background
Current successes in chemotherapy for acquired immune
deficiency syndrome (AIDS) are partly based on struc-
ture–function analysis of the replication enzymes reverse
transcriptase and protease. The structure of the third pol-
encoded replication enzyme, integrase, has been elusive
thus far, but the structures of two of its three domains, the
catalytic core and the carboxy-terminal DNA-binding
domain, have been solved. Here, we report the solution
structure of the remaining amino-terminal domain.
Integrase catalyses two distinct reactions: site-specific
cleavage of two nucleotides from both 3′ ends of the viral
DNA (cleavage reaction), and integration of the recessed
viral DNA into the target DNA (integration reaction) [1–4].
Three domains of the protein have been identified by
partial proteolysis [5] and deletion analysis [6,7] as well as
by in vitro complementation between mutant integrase pro-
teins [8,9]. The X-ray structure of a mutant of the catalytic
core of HIV-1 integrase has been solved [10], as well as that
of the core of integrase from avian sarcoma virus [11].
These structures resemble the structure of other polynu-
cleotidyl transferases such as ribonuclease H, RuvC
resolvase and MuA transposase [12–14]. The solution struc-
ture of the carboxy-terminal DNA-binding domain as deter-
mined by nuclear magnetic resonance (NMR) has been
reported to have a Src homology 3 (SH3)-like fold [15,16].
The amino terminus of integrase contains a putative zinc-
finger motif, HisX3–7HisX23–32CysX2Cys (HHCC), which
is conserved in all retroviral integrases and also in other
integrases such as those of Ty3 from yeast or copia from
Drosophila [17–19]. Although the exact role of this domain
is not known, it is required for cleavage and integration.
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Zinc binding by the first 55 amino acids of integrase has
been demonstrated in a zinc blot and by atomic absorption
spectroscopy [6,20,21]. Zinc induces folding in the amino-
terminal domain as well as in the full-length protein and
binds in an equimolar ratio [20,22]. In the full-length
protein, the presence of zinc promotes multimerization
and stimulates Mg2+-dependent cleavage [22–24]. Muta-
tions in the HHCC motif reduce zinc binding and impair
cleavage and integration [6,25,26]. These studies strongly
implicate the HHCC motif in zinc binding.
The primary sequence of the amino-terminal domain does
not show homology with any of the zinc-finger topologies
characterized thus far [27–30]. Previously, it has been sug-
gested that the structure of this domain might have simi-
larities with the structure of the CCHH zinc-finger
domain, which is found in transcription factor IIIA-like
peptides [20]. However, the three-dimensional solution
structure of the amino-terminal domain of HIV-2 inte-
grase, as reported here, shows no structural similarity with
any of the known zinc-finger structures.
Results and discussion
Zinc induces folding of IN1–55
NMR measurements showed that the amino-terminal
domain of HIV-2 integrase (hereafter named IN1–55) is
folded and stable over a pH range 5–8 in the presence of
ZnCl2. Removal of Zn2+ by EDTA results in unfolding of
the protein. Under reducing conditions the protein can be
refolded by adding Zn2+. A two-dimensional (1H,15N)-
HSQC spectrum of IN1–55 in the presence of zinc at
pH 6.5, at which the structural studies were performed, is
shown in Figure 1. Apart from signals corresponding to
amides of the folded protein, some weak peaks from the
unfolded form can be observed as well, indicating that the
affinity of the IN1–55 fragment for Zn2+ is relatively low. In
ROESY experiments, cross-peaks can be observed
between the Zn2+-containing folded and the unfolded
form of IN1–55, demonstrating that these two forms are in
slow exchange (data not shown).
In gel-filtration experiments, IN1–55 elutes at the position
of a dimer at a protein concentration of approximately
0.1 mM under similar conditions as used in the NMR
experiments. In an attempt to further characterize the
aggregation state, two-dimensional 13C and 15N/13C
double-half-filtered nuclear Overhauser effect (NOE)
experiments were performed on a mixture of unlabelled
and 15N/13C-labelled IN1–55. Since the sample was
obtained by adding Zn2+ to a mixture of unfolded unla-
belled and labelled IN1–55, heterodimeric molecules
should be formed in which one monomer is unlabelled
and the other contains the 15N/13C isotope labels. In the
half-filtered two-dimensional NOE spectra, however, no
clear intersubunit NOEs could be observed above the
artefact level. Various possible explanations can be offered
for this observation. One explanation would be that the
dimer forms weakly, if at all, under NMR conditions; this,
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Figure 1
Two-dimensional (1H,15N)-HSQC spectrum of
IN1–55 in the presence of zinc at pH 6.5. The
residues of the folded form are labelled by
residue names. The side chain NH2 signals of
glutamine and asparagine residues are
indicated by lines only. The unmarked NH
cross-peaks belong to the unfolded form.


9.20 8.80 8.40 8.00 7.60 7.20 6.80 6.40
136
130
124
118
112
N
 (p
pm
)
15
H (ppm)  1
S23
N38 V19
H16
L31
R34
L22
E6
C43
E21
N18
A49
N55
C40
A33
L2 I36V37
I5 Q35
Q45
K4Q44 I50
E11
K20
E10
K46H51 V54
E48
Q53
H24
F1,Q9
E13K25
H12
E3
Q42 V32
K14Y15
G47
G27 I28
S17F26
S39
A41
however, contradicts the gel-filtration experiments, which
suggest that dimers are already present at a concentration
of 0.1 mM. A more likely explanation is that there are sig-
nificant local motions at the dimer interface, which could
selectively broaden resonances originating from the inter-
face beyond detection. Therefore, we have focused in this
study on the monomeric fold of the protein.
IN1–55 structure determination
Sequence-specific resonance assignments were obtained
using two-dimensional and three-dimensional NMR (see
Materials and methods). NOE distance restraints were
obtained from two-dimensional NOE and three-dimen-
sional NOESY-(1H,15N)-HSQC spectra recorded on 600
and 750 MHz spectrometers. Various simulated annealing
calculations were performed using these restraints. Initial
calculations without any restraints for zinc coordination
showed that His12 coordinates zinc through the Nε2 atom,
whereas His16 coordinates zinc through Nδ1. This finding is
confirmed by the cross-peak pattern observed in a (1H,15N)-
HSMQC spectrum (see Supplementary mate-rial), which
shows that His12 is protonated at the Nδ1 atom, whereas
His16 is protonated at the Nε2 atom [31]. The region corre-
sponding to residues 47–55 is largely disordered due to a
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Figure 2
Overview of structural parameters of residues
1–46 of IN1–55. (a) Number of distance
restraints per residue. The restraints are
classified as long range, medium range,
sequential and intraresidual. (b, c) Root mean
square deviation (r.m.s.d.) for the backbone
Cα, N, C′ atoms and all heavy atoms versus
the residue number, respectively. The
structures are superimposed on the backbone
atoms of residues 3–44. (d) The angular
order parameter for the backbone angle φ. 
(e) The angular order parameter for the
backbone angle ψ.
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low amount of NOEs, and therefore this part of the protein
was not included in the final structure calculations. These
final calculations were performed with 693 NOE-derived
distance restraints (approximately 15 restraints per residue)
and were supplemented by a set of restraints to define the
proper tetrahedral coordination geometry around the zinc
ion. Figure 2a shows the distribution of NOEs over residues
1–46 of the IN1–55 sequence. Of 48 structures calculated, 20
structures were selected on the basis of low number of
NOE violations and low overall energies. Figure 3a shows a
superposition of the 20 selected structures, and a summary
of structural statistics is given in Table 1 and Figure 2.
Table 1 shows that very few NOE violations larger than
0.35 Å are present in the structures, indicating that the
implicit assumption that most NOEs would correspond to a
single monomer or subunit was a valid one. The region in
the structure corresponding to residues 3–44 is well defined
and displays a root-mean square deviation (r.m.s.d.) from
the average structure for the backbone atoms of 0.25 Å and
for all heavy atoms of 0.87 Å (see Figure 2b and 2c). Angular
order parameters for the backbone angles φ and ψ are
shown in Figure 2d and 2e, respectively. Figure 2 shows
that significant disorder in the backbone conformation is
limited to the amino and carboxyl termini. This disorder
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Figure 3
Solution structure of the amino-terminal
domain of HIV-2 integrase. (a) Stereoview of
a superposition of backbone traces (residues
1–46) of 20 calculated structures. The well
defined region is coloured yellow, the zinc
ions and the N-termini (residues 1–2) are
coloured green and the C-termini (residues
45–46) are coloured purple. (b) Schematic
view of the structure. The structure closest to
the average is presented. (c) Coordination
topology of the zinc centre.
can be accounted for by the low number of long-range
NOEs. A PROCHECK analysis of the structures [32]
showed that more than 77% of all residues (excluding
glycines and prolines) are in the most favoured region of the
Ramachandran plot and less than 0.5% of all residues are in
the disallowed region. The coordinates have been
deposited at the Brookhaven protein databank, pdb acces-
sion code 1AUB. 
Structure of the HHCC domain
Figure 3b shows a ribbon diagram of the folding topology
of IN1–55. The structure consists of three α helices, which
range from residues 6–15, 19–25 and 31–39. In addition,
medium-range NOEs indicate the presence of a helical
turn for residues 41–44. The three-helix bundle is stabi-
lized by a zinc-binding unit that is located near the car-
boxyl termini of the first and the third helix. The
zinc-binding unit is formed by His12, which coordinates
zinc through the Nε2 atom, by His16, which coordinates
zinc via Nδ1, and by Cys40 and Cys43, which coordinate
zinc through their sulfur atoms. Figure 3c shows the metal
coordination of the HHCC motif. The Nε2-coordinated
His12 is located in the last turn of the first helix, whereas
the Nδ1-coordinated His16 is located just outside this helix
(see Figure 3b). This coordination is consistent with the
observation that helical histidine residues generally coor-
dinate a metal through Nε2, whereas non-helical histidines
can coordinate metals via Nδ1 or Nε2 [33]. We note that
this coordination is different from previous zinc-finger
structures. In the classical CCHH zinc fingers, the two
helical histidines coordinate zinc through Nε2, while Nδ1
coordination was found for the non-helical histidine in the
CCHC zinc-binding motif of the LIM domain [34], as
well as in the CHCC zinc-binding motif of the RING
finger domain [35,36]. The residues of the HHCC motif
are strongly conserved in all retroviral integrases and the
previous conclusion that these residues would be involved
in zinc coordination is strongly supported by our analysis
of the solution structure.
Apart from the residues of the HHCC motif, various other
residues are well conserved in integrases of immunodefi-
ciency viruses (Figure 4). Of these residues, Ile5, Ala8,
Leu22, Ile28, Ala33 and Ile36 form part of the hydropho-
bic core, which explains their importance for structural
integrity (note that Ile28 is conservatively substituted by
leucine in most sequences). Other well conserved
hydrophobic residues are Pro29, which is located in the
turn between helix 2 and 3, and Phe26 and Val32. In the
structure, Phe26 and Val32 are partly exposed at the
surface and, therefore, it is difficult to conclude whether
their role is structural or whether they are involved in
interactions with other molecules.
Structural similarity to the DNA-binding three-helix bundles
Possible structural similarity of IN1–55 to other proteins was
investigated with the Dali Web server [37]. The overall
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Figure 4
Amino acid sequences of integrase from
human immunodeficiency virus type 2 (HIV-2),
type 1 (HIV-1), simian immunodeficiency virus
(SIV), feline immunodeficiency virus (FIV),
bovine immunodeficiency virus (BIV) and
equine infectious anaemia immunodeficiency
virus (EIAV). Residues that are identical in at
least five sequences are shown in bold. The
position of the three α helices of IN1–55 is
indicated above the sequences.
HIV-2  FLEKIEPAQEEHEKYHSNVKELSHKFGIPNLVARQIVNSCAQCQQKGEAIHGQVN
HIV-1  FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVD
SIV    FLEKIEPAQEEHDKYHSNVKELVFKFGLPRIVARQIVDTCDKCHQKGEAIHGQVN
FIV    WVDRIEEAEINHEKFHSDPQYLRTEFNLPKMVAEEIRRKCPVCRIIGEQVGGQLK
BIV    FLENIPSATEDHERWHTSPDILVRQFHLPRRIAKEIVARCQECKRTTASPVRGTN
EIAV   WVENIQEAQDEHENWHTSPKILARNYKIPLTVAKQITQECPHCTKQGSGPAGCVM
       1         11        21        31        41        51
helix 1 helix 2 helix 3
Table 1
Structural statistics for HIV-2 IN1–55*.
Number of distance restraints
All 693
Intraresidue 264
Sequential 172
Medium range 154
Long range 103
R.m.s.d. from average structure (Å)†
Backbone (N, Cα, C′) 0.25 ± 0.08
All heavy atoms 0.87 ± 0.11
R.m.s.d. from experimental distance restraints (Å)
All 0.048 ± 0.003
Deviations from idealized covalent geometry
Bonds (Å) 0.0042 ± 0.0003
Angles (°) 0.61 ± 0.03
Impropers (°) 0.67 ± 0.02
Average number of experimental distance
restraints violated by more than 0.35 Å 0.60
Maximum distance restraint violation (Å) 0.50
Percentage of residues with φ/ψ‡ in:
Most favoured regions 77.8%
Additionally allowed regions 16.1%
Generously allowed regions 5.7%
Disallowed regions 0.4%
*Structural statistics are presented for the 20 final simulated annealing
structures for residues 1–46. †Residues 3–44 (r.m.s.d., root mean
square deviation). ‡Residues excluding glycines and prolines.
folding topology turns out to be similar to that of several
DNA-binding three-helix bundle folds, as classified by the
SCOP database [38]. The backbone atoms of IN1–55 super-
impose with an r.m.s.d. of 2.1 Å on the equivalent region
of the trp repressor (41 residues, [39]) and with 2.2 Å on
both the prd paired domain (40 residues, [40]) and the
biotin repressor BirA (38 residues, [41]). Interestingly,
BirA contains an SH3-like fold at the carboxyl terminus
and a three-helix bundle in the amino-terminal part, simi-
larly to integrase. Another remarkable observation is that
the amino-terminal DNA-binding domain of the trans-
posase Tc3A, a protein with functional similarity to inte-
grase, has the same type of fold as IN1–55 [42]. The
structurally equivalent regions of IN1–55, the trp repressor,
the prd paired domain and transposase Tc3A are shown in
Figure 5. Within the DNA-binding three-helix bundle, the
second and third helices form a helix-turn-helix (HTH)
motif in which the third, so-called recognition, helix binds
DNA. The second and third helices of IN1–55 are similar to
the HTH motif found in both prokaryotic and eukaryotic
DNA-binding proteins. These helices of IN1–55 form an
angle of 124° with each other, the buried residues at posi-
tion 4 and 15 of the HTH motif correspond to the core
residues Leu22 and Ala33, respectively, and the com-
monly occurring glycine at position 9 is also a glycine in
IN1–55 (see Figure 4). The HTH motif of IN1–55 superim-
poses on the equivalent Cα atoms of several HTH motifs
(Figure 6) with an r.m.s.d. ranging from 1.2 Å for the prd
paired domain [40] to 1.4 Å for the trp repressor [39].
It has been suggested that the amino terminus of integrase
is involved in the recognition of viral DNA [26,43].
However, at present it is not clear whether the three-helix
bundle of IN1–55 binds DNA, or whether it interacts with
other domains of integrase [44,45], thereby affecting viral
DNA recognition.
Conclusions
The amino-terminal domain of HIV-2 integrase has a
remarkable hybrid structure combining features of a
three-helix bundle fold with a zinc-binding HHCC motif.
This three-helix bundle shows considerable structural
similarity to several DNA-binding proteins containing an
HTH motif. In integrase, the zinc is required for stabi-
lization of this three-helix bundle. This structure presents
a new fold for a zinc-binding motif. The strictly con-
served residues of the HHCC motif of retroviral inte-
grases are involved in coordinating the metal ion. Many
other well conserved hydrophobic residues are part of the
protein core, whereas the conserved Pro29 is in the turn
between helix 2 and 3.
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Figure 6
Superposition of Cα traces of the HTH motif of IN1–55 (residue 19–38)
on the HTH-motifs of six DNA-binding three-helix bundles. The bold Cα
trace is from IN1–55, the others (with the pdb entry given in
parentheses) are from: MATa1 homeodomain (1yrn), trp repressor
mutant V58I (1jhg), prd paired domain (1pdn), CAP (1ber), Oct-1 POU
homeodomain (1oct), and biotin repressor BirA (1bia).
Figure 5
The folding topology of IN1–55 and the equivalent regions of three DNA-
binding three-helix bundles. Shown are: IN1–55; TRP, trp repressor
mutant V581 (pdb entry 1jhg); PRD, amino-terminal subdomain of the
prd paired domain (pdb entry 1 pdn); Tc3A, transposase Tc3A.
While this paper was being reviewed, the structure of the
amino-terminal region of HIV-1 integrase was published
[46]. In contrast to the HIV-2 amino terminus, the amino
terminus of HIV-1 (residues 1–55) exists in two intercon-
verting folded states. This difference is clearly visible in
the corresponding (1H,15N)-HSQC spectra; in the case of
HIV-1, many residues display a doubling of the cross-
peaks. One of the forms shows the same folding topology
as HIV-2 IN1–55. In the other form, the histidines are coor-
dinated differently to the zinc and large conformational
differences occur for residues 9–18. Another important dif-
ference is that the structure of HIV-1 IN1–55 was solved as
a dimer. Several of the hydrophobic residues that are part
of the interface in HIV-1 IN1–55 are not hydrophobic in
the HIV-2 protein (Pro30 → N30; A38 → N38;
L45 → Q45, see Figure 4) and a potential salt bridge in
the interface of HIV-1 IN1–55 can not be formed in HIV-2
IN1–55 (E35 → Q35). These differences are likely to affect
the nature of the dimer interface. A consequence might be
an enhanced mobility of the interfacial residues for HIV-2
IN1-55, which may explain our difficulty in detecting inter-
subunit NOEs by NMR for HIV-2 IN1–55.
With the elucidation of the structure of the amino-termi-
nal domain, structural information is now available for all
three domains of HIV integrase. Nevertheless, in order to
define the topology of the whole protein, it still remains
important to determine the structure of intact integrase.
Materials and methods
IN1–55 preparation
The coding region of the 55 amino-terminal amino acids of HIV-2 IN was
amplified by polymerase chain reaction (PCR) from pRP279 [47] and
fused in frame to the 3′ end of the GST gene in vector pGEX-2T. The
resulting construct (pRP1021) was expressed in Escherichia coli
BL21(DE3). The cells were sonicated in buffer A, containing 0.5 M NaCl,
25 mM Hepes, pH 7.6, 0.1 mM EDTA and 3 mM β-mercaptoethanol.
After centrifugation at 10,000× g for 30 min, the supernatant was diluted
2.5 times with buffer A without NaCl and bound to glutathione
Sepharose 4B (Pharmacia). The column was washed with buffer A con-
taining 200 mM NaCl (buffer B) with 0.1% Tween, and with buffer B
without Tween. The protein was eluted with 20 mM glutathione in buffer
B. Top fractions were pooled and cleaved by thrombin (approximately 2.5
ΝΙΗ units/mg IN1–55) as described by the manufacturer (Sigma). IN1–55
was further purified by gel filtration on a HiLoad Superdex 75 column
(Pharmacia) and concentrated using Centriprep (Amicon). The protein
was dialysed to 3 M guanidine–HCl, 20 mM Tris, pH 8.3, 3 mM β-mer-
captoethanol, followed by a reduction step in 20% (v/v) β-mercap-
toethanol at 55°C for 1.5 h as described by Burke et al. [20].
Subsequently, the protein was purified over a C-18 reversed phase
HPLC column and eluted with a gradient of 5–70% (v/v) acetonitrile in
0.05% (v/v) trifluoroacetic acid. The top fractions were lyophilized and
kept under N2 gas to prevent oxidation. In addition to residues 1–55, the
protein fragment contains the sequence Gly–Ser–Met at the amino ter-
minus. Uniformly 15N-labelled or 15N/13C-labelled protein was prepared
by growing cells in minimal medium with 15NH4Cl and [U-13C]-glucose
as sole nitrogen and carbon sources, respectively. For the NMR experi-
ments, the lyophilized protein was dissolved in 50 mM deuterated Tris,
150 mM NaCl and 2 mM β-mercaptoethanol with 1.1 equivalent of
ZnCl2, either in 99.99% D2O or 95% H2O/5% D2O, and the pH was
adjusted to 6.5. Protein concentrations were approximately 3.5 mM.
Three types of NMR samples were used: uniformly 15N-labelled IN1–55 in
95% H2O/5% D2O; uniformly 15N-labelled IN1–55 in 99.99% D2O; and a
1:1 mixture of unlabelled and uniformly 15N/13C-labelled IN1–55 in 95%
H2O/5% D2O. The last sample was prepared by mixing the purified
unfolded labelled and un-labelled proteins after passage through the C-
18 reversed phase HPLC column. The lyophilized protein was then
folded by dissolving in the zinc-containing buffer as described above.
NMR spectroscopy and structure calculations
NMR spectra were recorded at 300 K on Bruker AMXT-600 and Varian
Unity+ 750 MHz spectrometers equipped with triple-resonance gradient
probes. Sequential assignments were obtained from sensitivity-enhanced
three-dimensional TOCSY-(1H,15N)-HSQC and NOESY-(1H,15N)-
HSQC, homonuclear two-dimensional NOE and TOCSY spectra in H2O.
Aromatic side chains were assigned using two-dimensional NOE and
TOCSY spectra in D2O. The protonation states of the histidines were
determined from a (1H,15N)-HSMQC spectrum recorded as described
by Zuiderweg [48]. The 13C and 15N/13C doubly half-filtered experiments
on the 1:1 mixture of unlabelled and uniformly 15N/13C-labelled IN1–55
were recorded as described by Folkers et al. [49] and Slijper et al. [50].
NOE distance restraints were obtained from two-dimensional NOE and
three-dimensional NOESY-(1H,15N)-HSQC spectra with mixing times of
50 and 100 msec. In the 50 msec NOE spectra, strong, medium and
weak peaks are visible and the corresponding upper distance bounds
were set to 2.9 Å, 3.6 Å and 4.5 Å. Additional very weak peaks observed
at 100 msec mixing time only were converted into an upper distance
bound of 6 Å. The lower distance bounds were set to 1.8 Å. In the final
calculations, no hydrogen bond restraints were included. Structure calcu-
lations were performed with X-PLOR, version 3.1 [51]. To correct for
multiple atom selections we used the sum-averaging option as imple-
mented in X-PLOR. Distance restraints containing diastereotopic groups
were corrected as described by Fletcher et al. [52]. The structures were
calculated using a dynamical simulated annealing protocol starting from
randomized coordinates [53]. The final structure calculations were
carried out in the presence of zinc. The zinc ion was modelled in the
protein structure file with a set of restraints to provide tetrahedral coordi-
nation of the zinc atom and to keep the zinc atom within the plane of the
histidine rings. Bond lengths were restrained to 2.0 Å for Zn-HisNε2 and
Zn-HisNδ1 and 2.3 Å for Zn-CysS. Bond angles were restrained to 126°
for Zn-HisNε2-HisCε1/Cδ2 and Zn-HisNδ1-Cε1/Cγ and to 100° for Zn-
CysSγ-CysCβ. The secondary structure elements were identified with the
Kabsch–Sander algorithm [54] as implemented in PROCHECK [32].
The well defined region for the overlays was selected on the basis of an
average φ and ψ angular order parameter larger than 0.85. Figures 3, 5
and 6 were prepared with the program MOLMOL [55].
Supplementary material
The (1H,15N)-HSMQC spectrum from which the tautomeric states of
the zinc-coordinating histidines were obtained is published with this
paper on the internet.
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